UMB Bank’s Vir Biotechnology VIR Stock Holding History

UMB Bank’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$175K	Buy	19,572 +12,510	+177%	+$99.7K	﹤0.01%	732
2025 Q4	$42.6K	Buy	7,062 +6,597	+1,419%	+$39.3K	﹤0.01%	1300
2025 Q3	$2.65K	Sell	465 -63	-12%	-$322	﹤0.01%	2010
2025 Q2	$2.66K	Buy	528 +104	+25%	+$558	﹤0.01%	1964
2025 Q1	$2.75K	Buy	424 +160	+61%	+$1.42K	﹤0.01%	1913
2024 Q4	$1.94K	Buy	264 +222	+529%	+$1.75K	﹤0.01%	1948
2024 Q3	$315	Sell	42 -75	-64%	-$651	﹤0.01%	2121
2024 Q2	$1.04K	Buy	117 +71	+154%	+$681	﹤0.01%	1964
2024 Q1	$466	Buy	+46	New	+$468	﹤0.01%	1998
2023 Q4	–	Sell	-1,549	Closed	-$14.5K	–	1754
2023 Q3	$14.5K	Buy	+1,549	New	+$22.1K	﹤0.01%	1164

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return